The role of viral fitness in HIV pathogenesis (Q36223846)

12 August 2017

1 reference

title

The role of viral fitness in HIV pathogenesis (English)

1 reference

12 August 2017

0 references

Robert M Grant

0 references

Jason D Barbour

1 reference

12 August 2017

publication date

1 February 2005

1 reference

12 August 2017

published in

Current HIV/AIDS reports

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

page(s)

29-34

1 reference

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

12 August 2017

cites work

1 reference

12 December 2020

Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection

1 reference

12 December 2020

Persistence of primary drug resistance among recently HIV-1 infected adults

1 reference

12 December 2020

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.

1 reference

12 December 2020

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

1 reference

12 December 2020

Infection of the SCID-hu mouse by HIV-1

1 reference

12 December 2020

Gag non-cleavage site mutations contribute to full recovery of viral fitness in protease inhibitor-resistant human immunodeficiency virus type 1.

1 reference

12 December 2020

Selected sexual practices of San Francisco heterosexual men and risk of infection by the human immunodeficiency virus

1 reference

12 December 2020

Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy

1 reference

12 December 2020

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

12 December 2020

Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues

1 reference

12 December 2020

Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques.

1 reference

12 December 2020

Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes.

1 reference

12 December 2020

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

1 reference

12 December 2020

Experimental HIV infection of human lymphoid tissue: correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1.

1 reference

12 December 2020

Pervasive genomic recombination of HIV-1 in vivo

1 reference

12 December 2020

Resistance-Associated Loss of Viral Fitness in Human Immunodeficiency Virus Type 1: Phenotypic Analysis of Protease and gag Coevolution in Protease Inhibitor-Treated Patients

1 reference

12 December 2020

Fidelity of HIV-1 reverse transcriptase

1 reference

12 December 2020

Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults

1 reference

12 December 2020

Procedures for reliable estimation of viral fitness from time-series data.

1 reference

12 December 2020

CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy

1 reference

12 December 2020

10.1007/S11904-996-0006-1

Identifiers

DOI

1 reference

12 August 2017

1 reference